Novel Device Studied in Treatment of Refractory Overactive Bladder
SacralStim system for sacral neuromodulation has an electrode with 6, rather than 4, contact points
Overactive Bladder (OAB)
OVERACTIVE BLADDER (OAB)
BTX-A Safe, Effective for Overactive Bladder in Older Adults
A study of patients older than 70 years who had overactive bladder found that the vast major of them reported improvement urinary incontinence, urinary urgency, daytime urinary frequency, and nighttime frequency after intradetrusor injection of onabotulinumtoxinA.
Age-Related Overactive Bladder Linked to Metabolic Imbalance
BDNF proteolysis imbalance may be a potential biomarker and therapeutic target, new findings suggest.
Urinary Incontinence Poses Burden to Long-Term Care
Survey of nursing directors shows impact on residents, staff, including turnover
Overactive Bladder in Men Linked to Excessive Visceral Fat
In a Japanese study, men with vs without OAB had a significantly higher visceral fat area and visceral fat volume.
COVID-19 Infection Ups Risk for New or Worsening OAB Symptoms
COVID-19-associated cystitis appears to be a common problem among infected individuals.
Morbid Obesity Ups Odds of Multiple Urologic Conditions
Efforts to reduce obesity may cut the prevalence of these urological conditions.
Donepezil Tied to Risk for Overactive Bladder
Risk for overactive bladder varies across individual cholinesterase inhibitor drugs
Overactive Bladder, Urinary Incontinence Common in Middle-Aged Women
Age and menopause status tied to increased urinary symptoms in women
Botulinum Toxin’s Efficacy for Post-Prostatectomy OAB Varies by Subtype
Long-term post-prostatectomy urinary incontinence affects 3% to 10% of patients.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Overactive Bladder (OAB)
Loading... 
Loading...